{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:43:43Z","timestamp":1761504223244,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.yebeh.2020.107235","type":"journal-article","created":{"date-parts":[[2020,7,18]],"date-time":"2020-07-18T07:28:45Z","timestamp":1595057325000},"page":"107235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"PA","title":["West syndrome: A study of 26 patients receiving short-term therapy"],"prefix":"10.1016","volume":"114","author":[{"given":"Sebasti\u00e1n","family":"Fortini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela Reyes","family":"Valenzuela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorena","family":"Fasulo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Caraballo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.yebeh.2020.107235_bb0005","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: position paper of the ILAE commission for classification and terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2020.107235_bb0010","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1528-1157.1993.tb00456.x","article-title":"The idiopathic form of West syndrome","volume":"34","author":"Vigevano","year":"1993","journal-title":"Epilepsia"},{"year":"1976","author":"Lacy","series-title":"Infantile spasms","key":"10.1016\/j.yebeh.2020.107235_bb0015"},{"key":"10.1016\/j.yebeh.2020.107235_bb0020","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00442097","article-title":"Infantile spasms: etiological factors, clinical aspects, and long-term prognosis in 200 cases","volume":"135","author":"Matsumoto","year":"1981","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.yebeh.2020.107235_bb0025","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1469-8749.1981.tb08446.x","article-title":"Long term prognosis after infantile spasms. Statistical study of prognostic factors in 200 cases","volume":"23","author":"Matsumoto","year":"1981","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.yebeh.2020.107235_bb0030","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archneur.1982.00510130051013","article-title":"Use of valproic acid in treatment of infantile spasms","volume":"39","author":"Bachman","year":"1982","journal-title":"Arch Neurol"},{"issue":"4","key":"10.1016\/j.yebeh.2020.107235_bb0035","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0370-4475(86)80027-2","article-title":"Spasmes infantiles \u00e9pileptiques b\u00e9nins [Benign epileptic infantile spasms]","volume":"16","author":"Dulac","year":"1986","journal-title":"Rev Electroencephalogr Neurophysiol Clin"},{"key":"10.1016\/j.yebeh.2020.107235_bb0040","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejpn.2009.03.004","article-title":"Favourable prognostic factors with infantile spasms","volume":"14","author":"Riikonen","year":"2010","journal-title":"Eur J Ped Neurol"},{"key":"10.1016\/j.yebeh.2020.107235_bb0045","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s13760-016-0611-8","article-title":"Evaluation of ten prognostic factors affecting the outcome of West syndrome","volume":"116","author":"Yilmaz","year":"2016","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.yebeh.2020.107235_bb0050","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1469-8749.1981.tb08446.x","article-title":"Long-term prognosis after infantile spasms: a statistical study of prognostic factors in 200 cases","volume":"23","author":"Matsumoto","year":"1981","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.yebeh.2020.107235_bb0055","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1055\/s-2008-1059590","article-title":"A long-term follow-up study of 214 children with the syndrome of infantile spasms","volume":"13","author":"Riikonen","year":"1982","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.yebeh.2020.107235_bb0060","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1111\/j.1528-1157.1997.tb00063.x","article-title":"Vigabatrin versus ACTH as first-line treatment for infantile spasms: a randomized, prospective study","volume":"38","author":"Vigevano","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2020.107235_bb0065","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1469-8749.1990.tb16926.x","article-title":"Tuberous sclerosis and infantile spasms","volume":"32","author":"Riikonen","year":"1990","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.yebeh.2020.107235_bb0070","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1055\/s-2007-973477","article-title":"Visual field constriction is not limited to children treated with vigabatrin","volume":"30","author":"Wohlrab","year":"1999","journal-title":"Neuropediatrics"},{"issue":"Suppl. 5","key":"10.1016\/j.yebeh.2020.107235_bb0075","first-page":"S21","article-title":"The role of vigabatrin in the management of infantile epileptic syndromes","volume":"43","author":"Appleton","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2020.107235_bb0080","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1111\/j.1528-1167.2010.02657.x","article-title":"Infantile spasms: a U.S. consensus report","volume":"51","author":"Pellock","year":"2010","journal-title":"Epilepsia"},{"issue":"Suppl. 2","key":"10.1016\/j.yebeh.2020.107235_bb0085","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/epi4.12264","article-title":"Treatment of infantile spasms","volume":"3","author":"Hussain","year":"2018","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.yebeh.2020.107235_bb0090","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1111\/j.1528-1157.1999.tb02049.x","article-title":"Randomised, placebo controlled study of vigabatrin as first-line treatment of infantile spasms","volume":"40","author":"Appleton","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2020.107235_bb0095","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/ana.24594","article-title":"Response to treatment in a prospective national infantile spasms cohort","volume":"79","author":"Knupp","year":"2016","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2020.107235_bb0100","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1474-4422(16)30294-0","article-title":"Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open label trial","volume":"16","author":"O'Callaghan","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2020.107235_bb0105","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.eplepsyres.2018.06.013","article-title":"Vigabatrin and high-dose prednisolone therapy for patients with West syndrome","volume":"145","author":"Ko","year":"2018","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2020.107235_bb0110","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.braindev.2015.05.012","article-title":"Predictive factors for relapse of epileptic spasms after adrenocorticotropic hormone therapy in West syndrome","volume":"38","author":"Hayashi","year":"2016","journal-title":"Brain Development"},{"key":"10.1016\/j.yebeh.2020.107235_bb0115","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1542\/peds.97.3.375","article-title":"High-dose corticotropin (ACTH) versus prednisone for infantile spasms: a prospective, randomized, blinded study","volume":"97","author":"Baram","year":"1996","journal-title":"Pediatrics"},{"key":"10.1016\/j.yebeh.2020.107235_bb0120","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0140-6736(04)17400-X","article-title":"The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial","volume":"364","author":"Lux","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.yebeh.2020.107235_bb0125","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.yebeh.2009.01.023","article-title":"High-dose oral prednisolone for infantile spasms: an effective and less expensive alternative to ACTH","volume":"14","author":"Kossoff","year":"2009","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2020.107235_bb0130","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/epi.12460","article-title":"Treatment of infantile spasms with very high dose prednisolone before high dose adrenocorticotropic hormone","volume":"55","author":"Hussain","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2020.107235_bb0135","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s40263-014-0139-5","article-title":"Recent advances in the pharmacotherapy of infantile spasms","volume":"28","author":"Riikonen","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1016\/j.yebeh.2020.107235_bb0140","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/dmcn.12573","article-title":"Does vigabatrin treatment for infantile spasms cause visual field defects? An international multicentre study","volume":"57","author":"Riikonen","year":"2015","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.yebeh.2020.107235_bb0145","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1528-1167.2008.01728.x","article-title":"Cerebral MRI abnormalities associated with vigabatrintherapy","volume":"50","author":"Pearl","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2020.107235_bb0150","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/epi.13712","article-title":"Risk of vigabatrin-associated brain abnormalities on MRI in the treatment of infantile spasms is dosedependent","volume":"58","author":"Hussain","year":"2017","journal-title":"Epilepsia"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505020304145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505020304145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:38:09Z","timestamp":1761503889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505020304145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":30,"alternative-id":["S1525505020304145"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2020.107235","relation":{},"ISSN":["1525-5050"],"issn-type":[{"type":"print","value":"1525-5050"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"West syndrome: A study of 26 patients receiving short-term therapy","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2020.107235","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107235"}}